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The atmospheric particles from different sources, and the therapeutic particles from various drug 
delivery devices, exhibit a complex size distribution, and the particles are mostly polydisperse. The 
limited available in vitro, and the wide range of in silico models have improved understanding of the 
relationship between monodisperse particle deposition and therapeutic aerosol transport. However, 
comprehensive polydisperse transport and deposition (TD) data for the terminal airways is still 
unavailable. Therefore, to benefit future drug therapeutics, the present numerical model illustrates 
detailed polydisperse particle TD in the terminal bronchioles for the first time. Euler-Lagrange approach 
and Rosin-Rammler diameter distribution is used for polydisperse particles. The numerical results 
show higher deposition efficiency (DE) in the right lung. Specifically, the larger the particle diameter 
(dp > 5 μm), the higher the DE at the bifurcation area of the upper airways is, whereas for the smaller 
particle (dp < 5 μm), the DE is higher at the bifurcation wall. The overall deposition pattern shows 
a different deposition hot spot for different diameter particle. These comprehensive lobe-specific 
polydisperse particle deposition studies will increase understanding of actual inhalation for particle 
TD, which could potentially increase the efficiency of pharmaceutical aerosol delivery at the targeted 
position of the terminal airways.
Airborne particles (dust, fumes, smoke, soot, droplets etc.) from various sources, and therapeutic drug particles 
from metered-dose inhalers (MDIs), dry-powder inhalers (DPIs) and nebulizers, are composed of complex size 
distributions. Particulates in the ambient air from natural and man-made sources include thoracic and respirable 
particles1, coarse inhalable particles (PM10), fine particles (PM2.5)2, and ultrafine particles. These polydisperse 
particles are inhaled through the extrathoracic and tracheobronchial airways and down into the terminal bron-
chioles3. Particulate matter (PM10) are mostly deposited in the extrathoracic and tracheobronchial airways due 
to strong inertial impaction and sedimentation4; whereas PM2.5 and ultrafine particle particulate matter could 
deposit at the alveolar airways5–7. Particulate matter (PM2.5) and ultrafine particles may interact with epithelium 
cells, vessels and submucosa of the airways8,9.
A therapeutic drug aerosol may be absorbed by the epithelium cells; and toxic airborne particles occur in 
different respiratory diseases by producing inflammation in the lung epithelium10. A fine particle could cross 
the alveolar epithelium wall to the interstitial space and finally, contact the blood stream of the lung capillary2. 
Because airborne particle size distribution is mostly polydisperse, these polydisperse particles are inhaled during 
breathing. Comprehensive polydisperse particle TD data for the extrathoracic and intrathoracic airways is still 
not available; therefore inclusive polydisperse particle TD for the entire lung model is important to better under-
stand actual particle TD in the lung airways.
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Extensive in vivo and in silico studies have been performed on monodisperse particle TD for both the extratho-
racic and intrathoracic regions of the lung11–19. The monodisperse particle TD study has improved understanding 
of airway deposition patterns for the upper airways. Relatively few studies have been conducted on polydisperse 
particle TD in the lung airways. The ambient and occupational settings of aerosol particulate matter are polydis-
perse20, and polydisperse particles have been associated with adverse respiratory health effects21. A series of data 
on monodisperse aerosol particle TD22 has been used to predict polydisperse particle TD in the human lung.
Lognormal size distribution is used for the theoretical study of regional and total deposition. Discrete mon-
odisperse fraction base size distribution shows greater error for regional deposition, especially for particle sizes 
smaller than 2 µm23. A series of monodisperse and polydisperse aerosol particle depositions in a packed bed 
shows higher total deposition for polydisperse particles than monodisperse particles20. The total 1- μm aerosol 
deposition in the packed bed without a charged neutralizer (an instrument which is used to neutralize the charge 
of the electronically charged aerosol particle) is 51% for polydisperse particles and 44% for monodisperse par-
ticles. An opposite deposition percentage is observed for a charged neutralizer system. The theoretical artificial 
neural network (ANN) prediction of polydisperse aerosol deposition in a human lung shows a more accurate 
deposition pattern (<0.025% error) for all regions of the lung24. An In Vivo study of radioactive polydisperse 
particle deposition in a child’s respiratory tract shows the extra thoracic deposition pattern25; a 72% ± 17% poly-
disperse aerosol (1 μm-9 μm) deposition was observed in the extrathoracic region.
A recent CFD study by26 for a ring less trachea model and a Zygote5 model showed a maximum 68.35% 
polydisperse particle deposition in the mouth piece and the entire lung model. Particles were injected from the 
Novolizer dry power inhaler device and spray entered the mouth in a conical fashion. The Zygote5 model consid-
ered first seven generations, and a ring structure was used in the trachea. No CFD or experimental study has been 
conducted which considers the entire branching pattern for polydisperse particle TD for a whole or large-scale 
lung model. To more accurately assess the polydisperse aerosol TD and respiratory health risk, it is important to 
investigate the various lobe specific studies.
The present study is the first approach to investigate polydisperse particle TD in the first 17 generations of 
an asymmetric lung model by considering a likely entire branching pattern. This study calculated the total air 
flow rate distribution at the five different lobes of a 17-generation model. A detail polydisperse particle TD was 
performed in the different lobes of the terminal airways and the deposition hot spot at the right and left lung, and 
different lobes was investigated.
Numerical Methods
Governing equations and boundary conditions. The present 17-generation anatomical model is pro-
posed by Schmidt, et al.27 and is an extension of the CFD study of Gemci, et al.28 and Islam, et al.6. Details of 
the anatomical model can be found in a previous computational study conducted by Islam, et al.6. An advanced 
meshing technique was used to generate the unstructured tetrahedral mesh for the complex anatomical model. 
A fine boundary inflation layer with dense hexahedral mesh was generated near the wall and the final geom-
etry contained approximately 34 million computational cells. Details about the meshing can be found in the 
Supplementary Section. A complete validation has been performed for the monodisperse particle TD, which can 
be found in the previous study by Islam, et al.6. The Large Eddy Simulation (LES) model was used to calculate 
the air flow in this study. Large eddies are calculated directly; on the contrary, the rest of the smaller eddies are 
calculated by using a Smagorinsky-Lilly subgrid-scale (SGS) model. The detail of the governing equations and 
boundary conditions can be found in the Supplementary Sections.
Particle initial distribution. A parabolic condition6,29 is used at the inlet surface. All the particles are 
injected through the inlet surface; a total 14,800 particles are injected. To check the convergence of the local 
particle deposition, a different number of particles are injected into the 17-generation model and found the local 
particle deposition fraction is no more than 1%. In order to minimize the discretization initialization time for 
the large-scale 17-generation model, a total 14,800 particles are injected for the final simulation. The flow rate is 
scaled by the face area and particles are injected through the face area. The detail particle properties and govern-
ing equations can be found in the Supplementary Section.
Figure 1 shows the polydisperse particle initial distribution at the inlet surface. Figure 1(a) shows the initial 
position of the different diameter particles; the initial distribution is coloured by a different diameter. The mini-
mum diameter 10−6 m, maximum diameters 10−5 m, and mean diameter 5×10−6 m is used in the Rosin-Rammler 
distribution method. Figure 1(b) shows the diameter distribution percentage plot. The diameter distribution plot 
shows a small percentage variation for different diameter particles; however, the initial position of the different 
diameter particle and the distribution percentage is random.
Results and Discussion
Air Flow Simulation. The present study accounts for airflow, polydisperse microparticle TD in a large-scale 
17-generation conduit model, and calculates flow rate distribution percentage in the five different lobes. The 
velocity contour at different selected planes of the upper airways are presented and which can be found in the 
Supplementary Section.
Table 1 shows the total flow rate distribution at the different lobes of the 17-generation model for different 
flow rates. The overall flow rate percentage shows that flow distribution is higher in the right lung than in the 
left. Total flow rate distribution also shows higher flow percentage at the right lower lobe than in all other lobes, 
and the lower flow distribution at the right middle lobe, compared to other lobes. The highly asymmetric ana-
tomical bifurcating branches significantly influence flow rate distribution at the different lobes. The benchmark 
experimental data of Cohen, et al.30 and Horsfield, et al.31 also show a similar trend of flow rate distribution at the 
different lobes, which satisfactorily supports the findings of the present study.
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Particle Transport and Deposition. The current study performs a comprehensive polydisperse particle 
TD by considering different deposition parameters. A wide range of micro-size particles (1 ≤ d μm ≤ 10) are con-
sidered for better prediction of polydisperse particle deposition at the terminal airways.
Polydisperse particle initial diameter distribution and total deposition comparison for different flow rates is 
shown in Fig. 2. The primary y-axis shows the DE of the deposited particles and the secondary y-axis shows the 
initial diameter distribution of the polydisperse particles. The overall DE of the polydisperse particle for differ-
ent flow rates shows an increasing trend, except at the 9 lpm flow rate. For the 9 lpm flow rate, the DE shows a 
fluctuating trend, and about 34% of injected 1- μm particles are deposited, while 42% of injected 10- μm particles 
are deposited. The DE for 25 lpm and 60 lpm flow rates shows an increasing trend, irrespective of particle diam-
eter. For a 60 lpm flow rate, 46.3% of 1- μm-sized particles are deposited and 93.1% of 10- μm sized particles are 
Figure 1. Polydisperse particle distribution, (a) schematic diagram of particle initial distribution at inlet and 
legend shows microparticle (μm) diameter, and (b) particle initial distribution curve based on diameter.
9 lpm 25 lpm 60 lpm




Right Upper Lobe 17.74 18.99 19.07 17.8 21.7
Right Middle Lobe 10.37 10.81 11.1 10.0 9.6
Right Lower Lobe 28.25 27.27 25.86 31.2 23.2
Left Upper Lobe 19.38 19.01 20.05 16.0 20.5
Left Lower Lobe 23.83 23.89 23.92 25.0 24.9
Right Lung 56.36 57.07 56.03 59 54.6
Left Lung 43.21 42.90 43.97 41 45.4
Table 1. Total flow rate distribution percentage at five different lobes.
Figure 2. Polydisperse particle initial diameter distribution and total deposition comparison for different flow 
rates.
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deposited. The calculated third order polynomial trend line fits comfortably with the DE curve for different flow 
rates. The third order analytical DE equation for the 60 lpm flow rate is:
= − . + . − . + .y x x x0 153 2 6851 7 3543 51 291 (1)3 2
The calculated R2 value is 0.9985, which clearly supports the curve fitting.
The third order analytical DE equation for the 25 lpm flow rate is;
= . − . + . + .y x x x0 0224 0 0273 1 0808 40 124 (2)3 2
with R2 value of 0. 9958, and the 4th order analytical DE equation for 9 lpm flow rate is;
= . − . + . − . + .y x x x x0 0159 0 3377 2 325 4 7352 36 287 (3)4 3 2
with the calculated R2 value is 0.8753.
The calculated third order polynomial analytical equation can be used for the validation purpose as it fits 
nicely with the present results. The analytical equations can also be used to predict the overall deposition pattern 
for a large scale model.
Figure 3 displays the polydisperse particle deposition pattern for a 17-generation whole lung model by exam-
ining the entire possible branching pattern. A wide range of micro-diameter particles (1 μm ≤ dp ≤ 10 μm) is 
considered in the present study, in which diameter is shown in different sizes and colours. Figure 3(a,c) show 
Figure 3. Polydisperse particle deposition pattern in a 17-generation anatomical model for different flow rates: 
(a) overall deposition pattern for 9 lpm flow rate, (b) enlarged portion of right upper lobe and right middle lobe, 
(c) overall deposition pattern for 60 lpm flow rate, and (d) enlarged portion of first and second bifurcation area.
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polydisperse particle deposition scenario for 9 lpm and 60 lpm flow rates respectively. Figure 3(b) shows enlarged 
deposition in the right upper lobe and part of the right middle lobe. Figure 3(d) shows the deposition pattern in 
the bifurcation area of the upper airway. The overall deposition pattern shows higher deposition concentration in 
the first few generations. At the 9 lpm flow rate, a lesser number of larger diameter particle (dp > 5 μm) are depos-
ited in the bifurcation area of the first and second generation compared to 60 lpm flow rate. Figure 3(b) shows a 
significant number of particles deposited in the bifurcation wall at the 9 lpm flow rate. For the 60 lpm flow rate, on 
the contrary, a significant amount of larger diameter (dp > 7 μm) particles are deposited in the bifurcation angle 
of the first and the second generation than in the 9 lpm flow rate. Figure 3(d) illustrates that fewer particles are 
deposited in the tracheal wall and the bifurcation wall at the 60 lpm flow rate. The enlarged deposition example 
also shows that smaller diameter particles are deposited mainly in the bifurcation wall, not at the carinal angle. 
Figure 3(a,d) show a noticeable amount of smaller diameter particles (dp < 5 μm) deposited at the terminal air-
ways for both flow rates. Moreover, a significant number of smaller diameter particles (dp < 5 μm) are deposited at 
the terminal airways of the 17-generation model in the 25 lpm flow rate; the deposition figure can be found in the 
Supplementary Section. The reason for this type of deposition is microparticle inertia, and the inertial impaction 
is the dominant mechanism. With increased particle diameter, the momentum relaxation time τm = ρpdp2Cs/18μ 
significantly increases and inertia becomes the vital component for the deposition32. Because of the higher inertia, 
larger diameter particles are deposited at the carinal angle area. A detailed discussion of the mechanism can be 
found in the authors’ previous work6. Inertial parameter (IP) can be defined as;
ρ=IP d Q (4)p
2
where ρ is the density, dp is the particle diameter and Q is the flow rate.
According to eqn. 4, inertial parameter value is increased regardless of flow rate and particle diameter. The 
inertial parameter value is significantly higher with a higher flow rate and larger diameter particles, which ulti-
mately indicates that inertial impaction is dominant for larger diameter particles and high flow rates. To investi-
gate the polydisperse particle deposition hot spot, deposited particle concentration curve has been calculated. The 
density curve and the detail discussion can be found in the Supplementary Section.
For better understanding of the polydisperse particle deposition, DE in the right lung and left lung has been 
investigated and third order analytical polynomial equations are derived from the DE curve. The detail discussion 
and the developed equations can be found in the Supplementary Section.
Figure 4 shows the lobar DE of a polydisperse particle for different flow rates. The DE for various diameter 
particles in the five different lobes is calculated. Figure 4(a) shows the lobar DE for a 9 lpm flow rate; different 
Figure 4. Lobar DE comparison for polydisperse particle: (a) 9 lpm flow rate, (b) 25 lpm flow rate, (c) 60 lpm 
flow rate.
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colours represent various lobes. The overall deposition DE shows higher deposition at the right upper lobes 
and lower deposition at the left upper lobes. The overall DE trend at the different lobes is fluctuating, which 
could reveal the size-specific deposition pattern at different lobes. Figure 4(a) shows that larger diameter par-
ticles are deposited mainly at the right upper lobes. Figure 4(a) also shows that the deposition concentration of 
4 μm ≤ dp ≤ 6 μm diameter particles are higher at the right lower lobes. However, for a 9 lpm flow rate, particles 
ranging from 6 μm ≤ dp ≤ 8 μm diameter are deposited mainly at the left lower lobes. The DE curve also illustrates 
that for lower flow rates, 6 μm and 7 μm diameter particle deposition concentrations are higher at the right mid-
dle lobe. Figure 4(b) shows the lobar deposition pattern for different diameter particles in five different lobes at 
25 lpm flow rates. The overall deposition pattern shows higher DE at the right upper lobe and lower DE at the 
left upper lobe. Figure 4(c) shows that the DE at the right lower lobe is higher, and lower at the left upper lobe. 
Figure 4(c) shows that the DE at the left upper lobe decreases with increased particle diameter; the main reasons 
for this are gravitational force and the anatomical structure of the left upper lobe. Because of gravity and the 
higher inertia of the microparticle, fewer micro-diameter particles enter into the left upper lobe.
The lobar deposition density comparison for different diameter particles reveals different deposition hot spots 
for various lobes, as shown in Fig. 5. At the right upper lobes, upper generations are the deposition hot spots 
and 10- μm diameter particle deposition concentration is higher than in particles of different diameters. On the 
contrary, the deposition density of the 7 μm ≤ dp ≤ 9 μm diameter particle is higher at the upper generation of the 
right middle lobe. Figure 5(d) shows different deposition hot spots at the left upper lobe for particles of different 
diameters.
Table 2 shows deposition hot spot for different diameter particle at 9lpm flow rate. The lobe-specific deposi-
tion concentration comparison for polydisperse particles significantly increases understanding of the pharmaceu-
tical particle deposition pattern at the terminal airways, which could advance respiratory health risk assessments.
Figure 5. Poly-disperse particle deposition density comparison during 9 lpm flow rate at (a) right upper lobe, 
(b) right middle lobe, (c) right lower lobe, (d) left upper lobe, (e) left lower lobe.
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Conclusions
A comprehensive air flow particle TD study has been performed in this study. The present large-scale respiratory 
model illustrates detail polydisperse particle TD for different flow rates using the Rosin-Rammler diameter dis-
tribution technique for polydisperse particle injection. The following conclusions can be drawn from the resulting 
study:
•	 Total flow rate distribution at the right lung is 1.3 times higher than that in the left lung and the total flow rate 
distribution at the lower lobes is higher than in the upper lobes. Specifically, minimum flow rate percentage 
is at the right middle lobe.
•	 Larger particle (dp > 5 μm) deposition concentration is higher at the bifurcation area (carinal angle) of the 
first couple of generations, whereas smaller diameter particle (dp < 5 μm) deposition concentration is higher 
at the bifurcation wall of the anatomical model.
•	 DE efficiency of the polydisperse particle is higher in the right lung than in the left lung, regardless of the flow 
rates.
•	 Polydisperse particle DE at the right upper lobe is higher compared to other lobes, except at 60 lpm flow rate, 
where DE is higher at the right lower lobe. Lower DE is observed at the left upper lobe, regardless of the flow 
rates.
•	 A different deposition hot spot is observed in the right and left lung for different diameter particles. At a 9lp 
flow rate, the deposition hot spot is in the upper and middle area of the right lung, and at the middle of the left 
lung. At 60 lpm flow rate, different deposition hot spots are observed for various diameter particles.
•	 Different deposition hot spots are observed at the different lobes of the 17-generation anatomical model for 
different diameter particles and flow rates.
•	 New analytical equations for the right and left lung DE, for different flow rates, have been developed and can 
be used to predict the DE for an entire lung model.
The present CFD study is the first comprehensive approach to demonstrate the polydisperse particle TD in 
different lobes of a large scale vasculature tree. The advanced CFD model performed inclusive lobar deposition 
and found different deposition hot spot for various deposition parameters. The present model developed new 
analytical equations for the deposition in the right lung, left lung and different lobes, which would potentially 
provide overall deposition understanding for a large scale model. The detail flow rate distribution calculation at 
different lobes will contribute to knowledge of air flow transport for a whole lung airway. Numerical predictions 
offer proven approximation of therapeutic aerosol particle deposition in the terminal airways of different lobes, 
generated from nebulizers, dry power inhalers and metered dose inhalers. The complete lobe-specific polydis-
perse particle TD study, together with clinical observations, will increase knowledge of site-specific drug delivery 
into the lower airways and the alveolar region of the lung. Detailed numerical prediction for lobar deposition will 
aid the pharmaceutical industry in the design of more efficient lobe-specific drug delivery and potentially advance 
the entire drug delivery sector. A more advanced, patient-specific case study will follow.
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